购物车
全部删除
您的购物车当前为空
别名 ADAC
Adenosine amine congener (ADAC) 是一种选择性的 A1 腺苷受体激动剂,具有神经保护作用,可以改善噪音和顺铂引起的耳蜗损伤。


为众多的药物研发团队赋能,
让新药发现更简单!
Adenosine amine congener (ADAC) 是一种选择性的 A1 腺苷受体激动剂,具有神经保护作用,可以改善噪音和顺铂引起的耳蜗损伤。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 673 | 现货 | |
| 5 mg | ¥ 1,650 | 现货 | |
| 10 mg | ¥ 2,480 | 现货 | |
| 25 mg | ¥ 4,190 | 现货 | |
| 50 mg | ¥ 5,990 | 现货 | |
| 100 mg | ¥ 8,270 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,080 | 现货 |
Adenosine amine congener 相关产品
| 产品描述 | Adenosine amine congener (ADAC) (ADAC) is an agonist of selective A1 adenosine receptor,. |
| 体内活性 | Adenosine amine congener (ADAC) 在噪声暴露后的最初24小时内,以超过50 μg/kg的剂量最为有效,能提供最高21 dB的保护(8-28 kHz范围内平均)。药动学研究显示,ADAC在静脉注射后,血浆中的半衰期短(5分钟),未检测到降解产物。 |
| 动物实验 | Adenosine amine congener (ADAC)??(25-300 μg/kg) was administered intraperitoneally to Wistar rats (8-10 weeks old) at intervals (6-72 hours) after exposure to traumatic noise (8-16 kHz, 110 dB sound pressure level, 2 hours). Hearing sensitivity was assessed using auditory brainstem responses (ABR) before and 12 days after noise exposure. Pharmacokinetic studies investigated ADAC concentrations in plasma after systemic (intravenous) administration[1]. |
| 别名 | ADAC |
| 分子量 | 576.6 |
| 分子式 | C28H32N8O6 |
| CAS No. | 96760-69-9 |
| Smiles | NCCNC(=O)Cc1ccc(NC(=O)Cc2ccc(Nc3ncnc4n(cnc34)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc2)cc1 |
| 密度 | 1.56 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 31.25 mg/mL (54.2 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.47 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容